Table 2:
mTIL Signatures | Age ≤ 40 (n=281) |
Age > 40 (n=1,111) |
Total (N=1,392) |
Mann-Whitney P Value |
---|---|---|---|---|
CD45 | .004 | |||
Mean | −0.2 | 0.0 | 0.0 | |
Median (range) | −0.2 (−2.4-2.4) | 0.0 (−2.8-2.9) | −0.1 (−2.8-2.9) | |
B cells | .09 | |||
Mean | −0.2 | 0.0 | 0.0 | |
Median (range) | −0.3 (−2.7-3.4) | −0.1 (−3.0-4.1) | −0.2 (−3.0-4.1) | |
CD8 T cells | .14 | |||
Mean | −0.1 | 0.0 | 0.0 | |
Median (range) | −0.1 (−2.8-2.3) | 0.0 (−3.0-2.5) | 0.0 (−3.0-2.5) | |
Cytotoxic cells | .03 | |||
Mean | −0.2 | 0.0 | 0.0 | |
Median (range) | −0.2 (−3.0-2.8) | 0.1 (−2.9-3.6) | 0.0 (−3.0-3.6) | |
Exhausted CD8 | .02 | |||
Mean | −0.1 | 0.0 | 0.0 | |
Median (range) | −0.1 (−1.3-1.4) | 0.0 (−1.4-2.2) | 0.0 (−1.4-2.2) | |
iDC | .17 | |||
Mean | −0.1 | 0.0 | 0.0 | |
Median (range) | −0.1 (−3.2-2.0) | 0.1 (−2.6-2.6) | 0.0 (−3.2-2.6) | |
Macrophages | .0003 | |||
Mean | −0.2 | 0.0 | 0.0 | |
Median (range) | −0.2 (−2.2-1.8) | 0.0 (−3.4-3.0) | 0.0 (−3.4-3.0) | |
Mast cells | .08 | |||
Mean | 0.1 | 0.0 | 0.0 | |
Median (range) | 0.2 (−5.3-4.5) | 0.1 (−5.4-4.5) | 0.1 (−5.4-4.5) | |
Neutrophils | .0005 | |||
Mean | −0.1 | 0.0 | 0.0 | |
Median (range) | −0.1 (−2.9-1.7) | 0.0 (−2.7-2.9) | 0.0 (−2.9-2.9) | |
NK-CD56dim cells | .001 | |||
Mean | −0.2 | 0.0 | 0.0 | |
Median (range) | −0.2 (−3.2-2.1) | 0.0, (−2.9-2.9) | 0.0 (−3.2-2.9) | |
T cells | .02 | |||
Mean | −0.1 | 0.0 | 0.0 | |
Median (range) | −0.2 (−2.6-2.4) | 0.0 (−2.9-2.5) | 0.0 (−2.9-2.5) | |
Treg | .04 | |||
Mean | −0.1 | 0.0 | 0.0 | |
Median (range) | −0.1 (−2.0-1.6) | 0.0 (−2.4-2.0) | 0.0 (−2.4-2.0) |
Abbreviations: iDC, immature dendritic cell ; mTIL, molecular tumor infiltrating lymphocyte; NCCTG, North Central Cancer Treatment Group; NK, natural killer; Treg, regulatory T cells